[1] Patent: CN105061399, 2017, B. Location in patent: Paragraph 0010; 0029; 0030
[2] Patent: US2011/287937, 2011, A1. Location in patent: Page/Page column 72-73
[3] Patent: WO2007/71900, 2007, A1. Location in patent: Page/Page column 94
[4] Yakugaku Zasshi, 1952, vol. 72, p. 1336,1338
[5] Chem.Abstr., 1953, p. 4336
[6] Zhao, B., Lan, Z., Xu, S., & Xiong, Y. (2017). Synthesis of 2-Chloronicotinic Acid Derivatives. Advances in Computer Science Research.
https://doi.org/10.2991/emcm-16.2017.119[7] Bi, S., Diao, W., Zhou, T., Lin, K., & Zhou, W. (2023). Development of a new synthetic route of the key intermediate of riociguat. Synthetic Communications, 53(21), 1844–1853.
https://doi.org/10.1080/00397911.2023.2252539[8] Chan, J., Burke, B., Baucom, K. D., Hansen, K., Bio, M., Divirgilio, E., Faul, M., & Murry, J. (2011). Synthesis of a CXCR3 Antagonist. Synfacts, 2011(06), 0583–0583.
https://doi.org/10.1055/s-0030-1259890